Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$192.5 - $216.35 $685,877 - $770,855
3,563 Added 4.32%
85,998 $17.5 Million
Q1 2024

Apr 16, 2024

BUY
$209.01 - $232.56 $227,193 - $252,792
1,087 Added 1.34%
82,435 $18 Million
Q4 2023

Feb 06, 2024

BUY
$197.69 - $227.29 $1.05 Million - $1.21 Million
5,309 Added 6.98%
81,348 $18.5 Million
Q3 2023

Nov 09, 2023

BUY
$201.05 - $221.7 $1.23 Million - $1.36 Million
6,123 Added 8.76%
76,039 $15.3 Million
Q2 2023

Aug 03, 2023

BUY
$211.93 - $241.33 $908,755 - $1.03 Million
4,288 Added 6.53%
69,916 $16.9 Million
Q1 2023

May 05, 2023

SELL
$213.32 - $257.83 $103,033 - $124,531
-483 Reduced 0.73%
65,628 $15.1 Million
Q4 2022

Feb 02, 2023

BUY
$203.72 - $248.97 $398,272 - $486,736
1,955 Added 3.05%
66,111 $15.6 Million
Q3 2022

Nov 04, 2022

BUY
$204.81 - $262.19 $406,138 - $519,922
1,983 Added 3.19%
64,156 $13.1 Million
Q2 2022

Aug 04, 2022

BUY
$213.86 - $277.87 $859,717 - $1.12 Million
4,020 Added 6.91%
62,173 $14.6 Million
Q1 2022

May 03, 2022

SELL
$259.82 - $298.18 $41,051 - $47,112
-158 Reduced 0.27%
58,153 $15.3 Million
Q4 2021

Feb 11, 2022

BUY
$271.6 - $314.21 $45,357 - $52,473
167 Added 0.29%
58,311 $18.3 Million
Q3 2021

Nov 02, 2021

SELL
$274.82 - $308.34 $369,083 - $414,100
-1,343 Reduced 2.26%
58,144 $16.4 Million
Q2 2021

Aug 05, 2021

SELL
$251.87 - $278.14 $3,274 - $3,615
-13 Reduced 0.02%
59,487 $17.9 Million
Q1 2021

May 07, 2021

BUY
$204.88 - $255.03 $19,258 - $23,972
94 Added 0.16%
59,500 $15.2 Million
Q4 2020

Feb 11, 2021

SELL
$186.91 - $214.42 $312,887 - $358,939
-1,674 Reduced 2.74%
59,406 $12.1 Million
Q3 2020

Oct 30, 2020

BUY
$167.03 - $201.3 $575,585 - $693,679
3,446 Added 5.98%
61,080 $11.5 Million
Q2 2020

Aug 06, 2020

BUY
$113.31 - $182.44 $563,150 - $906,726
4,970 Added 9.44%
57,634 $9.57 Million
Q1 2020

Apr 09, 2020

BUY
$104.32 - $195.28 $773,741 - $1.45 Million
7,417 Added 16.39%
52,664 $6.66 Million
Q4 2019

Jan 30, 2020

BUY
$163.48 - $173.61 $108,714 - $115,450
665 Added 1.49%
45,247 $7.65 Million
Q3 2019

Nov 12, 2019

BUY
$159.77 - $178.1 $285,189 - $317,908
1,785 Added 4.17%
44,582 $7.49 Million
Q2 2019

Aug 13, 2019

SELL
$144.16 - $172.9 $18,020 - $21,612
-125 Reduced 0.29%
42,797 $7.4 Million
Q1 2019

May 14, 2019

BUY
$123.7 - $156.3 $2.44 Million - $3.08 Million
19,725 Added 85.03%
42,922 $6.57 Million
Q4 2018

Feb 13, 2019

BUY
$120.82 - $174.09 $154,649 - $222,835
1,280 Added 5.84%
23,197 $2.93 Million
Q3 2018

Nov 14, 2018

BUY
$167.67 - $188.27 $838 - $941
5 Added 0.02%
21,917 $3.81 Million
Q1 2018

May 09, 2018

SELL
$161.53 - $178.11 $16,153 - $17,811
-100 Reduced 0.45%
21,912 $3.54 Million
Q3 2017

Nov 13, 2017

SELL
$149.47 - $160.56 $14,947 - $16,056
-100 Reduced 0.45%
22,012 $3.32 Million
Q2 2017

Aug 11, 2017

BUY
N/A
22,112
22,112 $3.41 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.6B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Clifford Swan Investment Counsel LLC Portfolio

Follow Clifford Swan Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.